Cui_2023_Diabetes.Obes.Metab__

Reference

Title : A model-informed approach to accelerate the clinical development of cofrogliptin (HSK7653), a novel ultralong-acting dipeptidyl peptidase-4 inhibitor - Cui_2023_Diabetes.Obes.Metab__
Author(s) : Cui C , Cao F , Kong, II , Wu Q , Li F , Li H , Liu D
Ref : Diabetes Obes Metab , : , 2023
Abstract : Cui_2023_Diabetes.Obes.Metab__
ESTHER : Cui_2023_Diabetes.Obes.Metab__
PubMedSearch : Cui_2023_Diabetes.Obes.Metab__
PubMedID: 37953687

Related information

Citations formats

Cui C, Cao F, Kong, II, Wu Q, Li F, Li H, Liu D (2023)
A model-informed approach to accelerate the clinical development of cofrogliptin (HSK7653), a novel ultralong-acting dipeptidyl peptidase-4 inhibitor
Diabetes Obes Metab :

Cui C, Cao F, Kong, II, Wu Q, Li F, Li H, Liu D (2023)
Diabetes Obes Metab :